SciClone Pharmaceuticals

SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. Its proprietary lead product, ZADAXIN (thymalfasin), may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals.